贝达药业：公司与武汉禾元生物科技股份有限公司已达成重组人白蛋白注射液（水稻）的商业化区域合作

Group 1 - The company, Betta Pharmaceuticals (300558.SZ), announced a commercial cooperation with Wuhan Heyuan Biotechnology Co., Ltd. for the regional commercialization of recombinant human albumin injection (rice-based) [1] - The recombinant human albumin product is considered breakthrough, with clinical research showing efficacy comparable to human plasma albumin while overcoming safety risks associated with blood sources [1] - The company holds a 5.6% stake in Heyuan Biotechnology, which is currently under a lock-up period lasting one year post-IPO [1]